Although executive enthusiasm for decentralization of clinical trials has grown significantly, operationalizing these models requires meticulous planning and risk-based quality management.

In an Applied Clinical Trials article, our DCT experts share what the future holds for the clinical trial industry as we implement more decentralized and hybrid approaches. 

Read the Article
Screenshot (1281)